Saatja: Webdesktop <
[email protected]>
Saadetud: 15.10.2021 14:20
Adressaat: SM Info <
[email protected]>; info ravimiamet ee <
[email protected]>;
Elen Ohov <
[email protected]>
Koopia: <
[email protected]>; <
[email protected]>
Teema: Webdesktop: Kiri nr 14-4/1090/ Eesti esindajate nimetamine Euroopa
Ravimiameti (EMA) haldusnõukogusse
Tere!Edastan Euroopa Ravimiameti kirja. Nimetamine käib EV alaline
esindus EL juures kaudu. Palun saata esindajate nimed, nende
täiskontaktandmed ning ametiaja algus meie e-posti aadressile
[email protected], cc.
[email protected] .Reg. number: 14-4/1090Reg.
kuupäev: 15.10.2021Sisu: Eesti esindajate nimetamine Euroopa Ravimiameti
(EMA) haldusnõukogusse / Nomination of representatives in the Management
Board (MB) of the European Medicines AgencyHeade soovidegaTiiu
[email protected]är, EV alaline esindus EL juures+32
22274337
Saatja: Albuquerque Sophia <
[email protected]>
Saaja: Esindus EL juures üldaadress,
[email protected]
Teema: Estonia_2021.10.13_Nomination Reminder letter for the EMA Management Board
Your Excellency,
Please find attached a letter signed by the European Medicines Agency's Executive Director requesting the nomination of representatives to the Management Board.
You are kindly invited to address nominations to the European Medicines Agency’s Executive Director Emer Cooke.
Please do not hesitate to contact me should you have any questions regarding this request for nomination.
Nominees will be subject to a pre-screening of any declared competing interest in line with the Agency's policy on handling of competing interests. In case of a negative outcome, the Agency will provide feedback of this screening to the nominating authority for subsequent consideration.
Your sincerely,
Sophia Albuquerque
Sophia Albuquerque
Management Board Secretariat
European Medicines Agency
Domenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands
Tel. +31 (0)88 781 6918
[email protected]<mailto:
[email protected]> | www.ema.europa.eu<http://www.ema.europa.eu/> | For directions, see How to find us<https://www.ema.europa.eu/en/about-us/contact/how-find-us>
[EMA_logo]<http://www.ema.europa.eu/ema/>
This message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this email, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this email in error, please inform the sender immediately.
Classified as confidential by the European Medicines Agency
________________________________________________________________________
This e-mail has been scanned for all known viruses by European Medicines Agency.
________________________________________________________________________
HE Mr Aivo Orav
Permanent Representation of Estonia
to the European Union
Rue Guimard 11-13
B-1040 Brussels
BELGIUM
13 October 2021
EMA/581516/2021
Executive Director
Your Excellency,
Subject: Nomination of representatives in the Management Board (MB) of the European
Medicines Agency
In accordance with Regulation (EC) No 726/2004, members and alternates of the European Medicines
Agency’s Management Board and scientific committees are nominated for a three-year mandate by EU
member states and EEA-EFTA countries.
The three-year mandate of the representative listed below is due to expire. I, therefore, invite you to
nominate representative for a new three-year mandate starting from the date indicated below. In case
you are nominating new representatives and a different start date for the mandate is envisaged,
please inform me accordingly.
Alar Irs Alternate 18 May 2022
Following Kristin Raudsepp’s resignation notified to the Agency on 12 August 2021, the member’s
mandate for your country in the Management Board is now vacant. I, therefore, invite you to nominate
a new representative for a new three-year mandate, and inform me of the start date of the mandate.
Please address the nominations to my attention at PO Box 71010, 1008 BA Amsterdam, The
Netherlands, indicating full contact details for the nominees and the start date of the mandate,
together with any additional information you believe may assist these nominations. In case you have
already provided me with your nominations, I kindly ask you to disregard this correspondence.
Yours faithfully,
Emer Cooke Digitally signed by Emer Cooke
Date: 2021.10.15 09:38:03 +02'00'
Emer Cooke
Executive Director
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union
© European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged.